GENASE THERAPEUTICS
Genase Therapeutics is the developer of therapeutic products intended to treat solid tumors. The company develops small molecule inhibitors against a metabolic target with therapeutic potential in hematologic malignancies as well as conducting research in the field of oncology, providing pharmaceuticals and healthcare professionals with biotechnological research and development work in the field of oncology.
GENASE THERAPEUTICS
Industry:
Therapeutics
Address:
Oss, Noord-Brabant, The Netherlands
Country:
The Netherlands
Status:
Active
Similar Organizations
CanimGuide Therapeutics
CanimGuide Therapeutics is developing a therapeutic platform based around an extraordinary biologic concept.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Current Advisors List
More informations about "Genase Therapeutics"
Genase Therapeutics Company Profile 2024: Valuation, Funding ...
Genase Therapeutics General Information Description. Developer of therapeutic products intended to exploit metabolic vulnerabilities in oncogene addicted cancers. The company …See details»
Genase Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Genase Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Genase Therapeutics - BioGeneration Ventures
Edward currently serves on the supervisory boards of Azafaros, Escalier BioSciences, Genase Therapeutics, Scenic Biotech, Staten Biotechnology, Synaffix and TigaTx. Read more Diede Brunen, PhD Principal. Diede has a …See details»
Genase Therapeutics - VentureRadar
Genase Therapeutics develops small molecule inhibitors of dihydroorotate dehydrogenase (DHODH), a critical enzyme in de novo pyrimidine biosynthesis and electron transport. ...See details»
Genase Therapeutics - Company Profile - Tracxn
Oct 19, 2024 Genase Therapeutics ranks 1,872nd among 2371 active competitors. 856 of its competitors are funded while 544 have exited. Overall, Genase Therapeutics and its …See details»
Genase Therapeutics - Funding, Financials, Valuation & Investors
Jan 1, 2019 Genase Therapeutics has raised 1 round. This was a Venture - Series Unknown round raised on Jan 1, 2019 . Genase Therapeutics is funded by BioGeneration Ventures .See details»
Genase Therapeutics - Crunchbase
Genase Therapeutics is the developer of therapeutic products intended to treat solid tumors.See details»
Navigating the right deals in oncology - Nature
Mar 21, 2023 Oncology is by far the most important area for dealmaking in the biopharma industry. The value of cancer deals for which financial details were disclosed reached $73.1 billion in 2021 and $93.1 ...See details»
GTX 0196 - AdisInsight - Springer
GTX 0196 is dihydroorotate dehydrogenase (DHODH inhibitor), being developed by Genase Therapeutics for the treatment of haematological cancer and Solid tumours. GTX 0196 Next ...See details»
Genase Therapeutics - Tech Stack, Apps, Patents & Trademarks
Genase Therapeutics is the developer of therapeutic products intended to treat solid tumors.See details»
GTX-0196 - Drug Targets, Indications, Patents - Synapse - Patsnap
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
Gilead and Genesis Therapeutics Announce Strategic …
Sep 10, 2024 - Gilead and Genesis Will Leverage the GEMS AI Platform to Generate and Jointly Optimize Molecules Against Selected Targets - - Gilead Receives Exclusive Rights to Develop …See details»
Genesis Therapeutics Company Profile 2024: Valuation, Funding ...
Genesis Therapeutics General Information Description. Developer of a computational platform designed for the discovery of small-molecule drugs. The company leverages a proprietary …See details»
Capturing the genAI boom for drug development
Jun 27, 2024 Genesis Therapeutics – an AI-led drug development startup raised $200m in a Series B round last year with backing from Eli Lilly. Evozyne, which puts proteins through …See details»
Genase Therapeutics - Updates, News, Events, Signals & Triggers
Genase Therapeutics is the developer of therapeutic products intended to treat solid tumors.See details»
Genase Therapeutics - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
Genesis Therapeutics Secures $52M Series A to Further Accelerate …
Dec 2, 2020 Genesis Therapeutics is a unique organization that revolves around a true collaboration between drug hunters, who have discovered and/or developed multiple FDA …See details»
Genase Therapeutics - Contacts, Employees, Board Members
Organization. Genase Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Genase Therapeutics has 1 board …See details»
Genesis Therapeutic - Crunchbase Company Profile & Funding
Genesis Therapeutics is a company that has its roots in academic research, which serves as the foundational element of its growing portfolio of AI technologies. The company employs a …See details»